Skip to content

Ibogaine research published in 2023

22 studies whose primary subject is ibogaine were published in 2023, up from 14 in 2022. Newest first. Back to the ibogaine overview

Studies

Psychedelic Therapy: A Primer for Primary Care Clinicians – Part V. Ibogaine

December 26, 2023 Kirsten Cherian, Kenneth Shinozuka, Burton J. Tabaac et al. preprint

Background: Ibogaine is a plant-derived alkaloid that has been used for thousands of years in rites of passage and spiritual ceremonies in West-Central Africa. In the West, it has primarily been used and studied for its anti-addictive properties and more recently for other neuropsychiatric indications, including post-traumatic stress disorder (PTSD), depression, anxiety, and traumatic brain...

Ibogaine and Noribogaine

The Oxford Handbook of Opioids and Opioid Use Disorder December 18, 2023 Deborah C. Mash, Michael Karukin

Abstract Ibogaine is an indole alkaloid derived from the root bark of Tabernanthe iboga. The anti-addictive actions of ibogaine were first reported in the 1960s by persons using heroin. They offered personal testimonials that single oral doses of ibogaine abruptly blocked opioid withdrawal, and they remained drug-free after ibogaine exposure. Today, online forums describe ibogaine use for...

Efeitos do tratamento com Ibogaína em dependentes de opióides: uma revisão integrativa

Brazilian Journal of Health Review December 15, 2023 Fernanda Leticia Dos Santos Matta, Vivian Frigo Batista, Alexandre Dantas Gimenes et al.

A Ibogaína é um alcalóide indólico psicoativo com efeitos estimulantes e alucinógenos o qual é derivado da casca da raiz do arbusto da África Ocidental Tabernanthe iboga, mostra-se uma alternativa promissora no tratamento de dependentes de substâncias derivadas do ópio por demonstrar uma afinidade significativa por muitos sistemas neurotransmissores. Avaliar os efeitos do tratamento com...

DOI: 10.34119/bjhrv6n6-415 (opens in new tab) Gynecology Pediatrics Anesthesia

Guidelines for Establishing Safety in Ayahuasca and Ibogaine Administration in Clinical Settings

Psychoactives December 11, 2023 Juliana Mendes Rocha, José Augusto Silva Reis, Giordano Novak Rossi et al. 3 citations

As the research field with psychedelic substances grows, it is expected to encompass a more extensive cohort of individuals presenting a spectrum of medical conditions, comorbidities, and unique physiological traits, thereby increasing the likelihood of potential adverse events. Furthermore, it is worth noting that there is a scarcity of the specialized literature regarding procedures to ensure...

DOI: 10.3390/psychoactives2040024 (opens in new tab) Ayahuasca Guideline Clinical trial Adverse effect +1

Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview.

Journal of Psychopharmacology December 1, 2023 Genís Ona, Ingrid Reverte, Giordano N. Rossi et al. 20 citations

There is a growing interest in studying ibogaine (IBO) as a potential treatment for substance use disorders (SUDs). However, its clinical use has been hindered for mainly two reasons: First, the lack of randomized, controlled studies informing about its safety and efficacy. And second, IBO's mechanisms of action remain obscure. It has been challenging to elucidate a predominant mechanism of...

DOI: 10.1177/02698811231200882 (opens in new tab) Full text (opens in new tab) Noribogaine Hallucinogen Substance use disorders Ibogaine therapy: ibogaine +10

22 The Effect of Ibogaine on Cognitive Functioning

Journal of the International Neuropsychological Society November 1, 2023 Kirsten Cherian, Afik Faerman, Lauren Anker et al.

Objective: To determine the effects of the non-classic psychedelic, ibogaine, on cognitive functioning. Ibogaine is an indole alkaloid derived from the Tabernanthe Iboga plant family, indigenous to Africa, and traditionally used in spiritual and healing ceremonies. Ibogaine has primarily been studied with respect to its clinical efficacy in reducing substance addiction. There are, however,...

DOI: 10.1017/s1355617723011049 (opens in new tab) Full text (opens in new tab) Memory span Verbal fluency test Neuropsychology Verbal learning +4

Ibogaine as a Treatment For Alcohol Use Disorder: a Preclinical Investigation

October 1, 2023 Sarah Falkenhaug 1 citation

Substance use disorders are a debilitating psychiatric condition which contribute to significant personal, legal and economic problems worldwide. Current treatment options, such as pharmaceutical interventions or behavioural therapy, are not always utilised or effective at reducing symptoms. Ibogaine, a psychedelic compound deriving from root bark of the Tabernanthe iboga plant, has shown...

Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies.

European Archives of Psychiatry and Clinical Neuroscience October 1, 2023 Juliana Mendes Rocha, José A S Reis, José Carlos Bouso et al. 21 citations

Ibogaine is a psychoactive alkaloid derived from the west-African shrub Tabernanthe iboga. Western cultures are increasing the interest for the substance due to its claimed anti addictive properties, although the evidence supporting this effect is still preliminary. The use of ibogaine often occurs with no medical supervision in uncontrolled settings, and its use has been associated with...

DOI: 10.1007/s00406-023-01590-1 (opens in new tab) Full text (opens in new tab) Noribogaine Ibogaine safety Controlled medical setting Clinical studies

Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico.

The American Journal of Drug and Alcohol Abuse September 3, 2023 Alan Kooi Davis, Yitong Xin, Nathan D. Sepeda et al. 29 citations

Background: Research in psychedelic medicine has focused primarily on civilian populations. Further study is needed to understand whether these treatments are effective for Veteran populations.Objectives: Here, we examine the effectiveness of psychedelic-assisted therapy among trauma-exposed Special Operations Forces Veterans (SOFV) seeking treatment for cognitive and mental health problems in...

Noribogaine effects on wakefulness and sleep

bioRxiv (Cold Spring Harbor Laboratory) July 28, 2023 Juan Pedro Castro-Nin, Diego Serantes, Paola Rodrı́guez et al. 1 citation preprint

Abstract Ibogaine is a potent atypical psychedelic that has gained considerable attention due to its antiaddictive and antidepressant properties in preclinical and clinical studies. Previous research from our group showed that ibogaine suppresses sleep and produces an altered wakefulness state which resembles natural REM sleep. However, after systemic administration, ibogaine is rapidly...

DOI: 10.1101/2023.07.26.550725 (opens in new tab) Full text (opens in new tab) Wakefulness Sleep system call Slow-wave sleep Antidepressant +3

Reactivity of the Iboga Skeleton: Oxidation Study of Ibogaine and Voacangine.

Journal of Natural Products June 23, 2023 Bruno González, Nicolás Veiga, Gonzalo Hernández et al. 7 citations

The iboga alkaloids scaffold shows great potential as a pharmacophore in drug candidates for the treatment of neuropsychiatric disorders. Thus, the study of the reactivity of this type of motif is particularly useful for the generation of new analogs suitable for medicinal chemistry goals. In this article, we analyzed the oxidation pattern of ibogaine and voacangine using dioxygen, peroxo...

DOI: 10.1021/acs.jnatprod.3c00189 (opens in new tab) Full text (opens in new tab) Drug development Drug discovery Medicinal chemistry Pharmaceutical research +17

0665 Ibogaine treatment in combat Veterans significantly improves sleep, beyond alleviating Posttraumatic Stress Disorder symptoms

Sleep May 1, 2023 Afik Faerman, Lauren Anker, Kirsten Cherian et al. 5 citations

Abstract Introduction Ibogaine is an indole alkaloid traditionally used in spiritual and healing rites in some African cultures. Ibogaine is primarily studied in the context of substance dependence, but indications suggest it may enhance recovery from trauma. Here, we investigated the effects of ibogaine treatment for multisystem effects of exposure to repeated blasts and combat on...

DOI: 10.1093/sleep/zsad077.0665 (opens in new tab) Full text (opens in new tab) Insomnia Posttraumatic stress Sleep disorder Context archaeology +2

IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.

Pharmacological Research April 1, 2023 Deborah C. Mash 37 citations

Ibogaine is a powerful psychoactive substance that not only alters perception, mood and affect, but also stops addictive behaviors. Ibogaine has a very long history of ethnobotanical use in low doses to combat fatigue, hunger and thirst and, in high doses as a sacrament in African ritual contexts. In the 1960's, American and European self-help groups provided public testimonials that a single...

Ibogaine: Ibogaine therapy as a method of care treatment for opioid dependence

Psychedelics as Psychiatric Medications March 1, 2023 Deborah C. Mash 1 citation

Abstract Ibogaine has been used as a botanical preparation from the root bark of Tabernanthe iboga for over one hundred years, both as a crude preparation and as semisynthetic ibogaine. Extracts derived from this plant have a long history of traditional medicinal and ceremonial use in Western Africa. Ibogaine is a polypharmacology drug that acts on several neurotransmitter systems, including...

DOI: 10.1093/med/9780192863607.003.0007 (opens in new tab) Ibogaine Plant-derived compound Medicinal compound Opioid addiction +18

Transpersonal Intersubjectivity in Ibogaine Experiences: Three cases

Anthropology of Consciousness February 6, 2023 Jonathan Dickinson 1 citation

ABSTRACT This report presents the personal experiences of three individuals who ingested iboga or ibogaine in different contexts and for different reasons. Narrative analysis reveals a connection with previously identified phenomenological categories of experience, however demonstrating a wide variability. Most notably, each of these interviewees reported a distinct impression of transpersonal...

DOI: 10.1111/anoc.12172 (opens in new tab) Intersubjectivity Narrative Transpersonal psychology Vision +4

Potent Anti-amoebic Effects of Ibogaine, Voacangine and the Root Bark Alkaloid Fraction of Tabernaemontana arborea.

Planta Medica February 1, 2023 Julio César Carrero, Violeta Curay-Herrera, Lysette Chacón-niño et al. 6 citations

Plants of Tabernaemontana species have several pharmacological activities including antimicrobial effects. Amoebiasis continues to be a public health problem, with increasing evidence of resistance to metronidazole. In this study, we assessed the effect of the alkaloid fraction of T. arborea root bark and the alkaloids ibogaine and voacangine on the viability and infectivity of Entamoeba...

DOI: 10.1055/a-1809-1157 (opens in new tab) Full text (opens in new tab) Ibogaine Amoebiasis *entamoeba histolytica* Parasitic infection +12

Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences.

Drug and Alcohol Review February 1, 2023 Borja J Rodríguez-cano, Maja Kohek, Genís Ona et al. 17 citations

Ibogaine is one of the alkaloids naturally found in plants such as Tabernanthe iboga, which has been traditionally used by members of the Bwiti culture. Since the discovery of its anti-addictive properties by Howard S. Lotsof in 1962, ibogaine has been used experimentally to treat substance use disorders (SUD), especially those involving opioids. We aim to provide a detailed understanding of...

DOI: 10.1111/dar.13587 (opens in new tab) Full text (opens in new tab) Psychedelic-assisted therapy Hallucinogenic Qualitative analysis Substance use disorders +15

What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.

Journal of Medicinal Chemistry January 12, 2023 Carolyn J Straub, Lisa E Rusali, Kyle M Kremiller et al. 19 citations

For decades, ibogaine─the main psychoactive alkaloid found in Tabernanthe iboga─has been investigated as a possible treatment for substance use disorders (SUDs) due to its purported ability to interrupt the addictive properties of multiple drugs of abuse. Of the numerous pharmacological actions of ibogaine and its derivatives, the inhibition of α3β4 nicotinic acetylcholine receptors (nAChRs),...

DOI: 10.1021/acs.jmedchem.2c01562 (opens in new tab) Full text (opens in new tab) Ibogaine: natural compound Plant medicine Drug addiction Suds +5